Cyclerion Therapeutics, Inc. (KRSA) vs Zenas BioPharma, Inc. (ZBIO)
Cyclerion Therapeutics, Inc. and Zenas BioPharma, Inc. are both Biotechnology companies. Cyclerion Therapeutics, Inc. and Zenas BioPharma, Inc. are of similar size ($1.8B and $1.7B). Across the 10 metrics below, Cyclerion Therapeutics, Inc. leads on 5 and Zenas BioPharma, Inc. on 5.
Valuation
Profitability
| Metric | KRSA | ZBIO | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | — | 65.16% |
| Operating margin | 0.00% | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% | 0.00% |
| Free cash flow margin | 0.00% | 0.00% | 0.00% |
| Return on equity | (98.22%) | (199.04%) | (57.72%) |
| Return on assets | (82.29%) | (97.39%) | (49.22%) |
| Return on invested capital | (115.40%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack